In line with our findings, previous studies showed that administration of anti-IL-17A or astragaloside IV, an IL-17 inhibitor, ameliorated chronic stress- and stroke-related anxiety, respectively (Sun et al., 2020a; Kim et al., 2021), suggesting a common role of IL-17A in anxiety that occurs in various CNS diseases. Here, IL17A is linked to Stroke.